Status:
SUSPENDED
Optimizing Treatment of Stage IV Breast Cancer Through Real-Time Disease Monitoring
Lead Sponsor:
Mayo Clinic
Conditions:
Anatomic Stage IV Breast Cancer AJCC v8
Metastatic Breast Carcinoma
Eligibility:
All Genders
18+ years
Brief Summary
This study evaluates if blood tests can detect changes in disease status during treatment for stage IV breast cancer. Information from this study may help researchers learn more about metastatic breas...
Detailed Description
PRIMARY OBJECTIVES: I. To identify subtype-specific signatures for breast cancer using genomic positioning of plasma deoxyribonucleic acid (DNA) fragments. II. To validate changes in circulating tum...
Eligibility Criteria
Inclusion
- Adults \> 18 years of age
- Stage IV breast cancer undergoing cancer treatment
Exclusion
- Stage I-III breast cancer
- Unwilling or unable to give consent
- Patients with a prior or concurrent malignancy, excluding non-melanoma skin cancers and non-invasive cancers whose natural history or treatment does not have the potential to interfere with the assessment of the investigational marker
Key Trial Info
Start Date :
November 16 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 30 2027
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT04906369
Start Date
November 16 2020
End Date
December 30 2027
Last Update
May 15 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mayo Clinic in Arizona
Scottsdale, Arizona, United States, 85259